Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03229941 · ClinicalTrials.gov registry record · NA
Transfusion Trigger After Operations in High Cardiac Risk Patients
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 1,424
- Enrollment target
NCT03229941: Completed NA study, sponsored by VA Office of Research and Development.
NCT03229941 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,424 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03229941, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,424 participants
- Enrollment target
Study Summary
The goal of the proposed study is to determine whether a liberal transfusion strategy (transfusion trigger at Hb \< 10 gm/dl) in Veterans at high cardiac risk who undergo major open vascular and general surgery operations is associated with decreased risk of adverse postoperative outcomes compared to a restrictive transfusion strategy (transfusion trigger at Hb \< 7 gm/dl).
Interventions
- PROCEDURE Blood Transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,424 participants |
| Start Date | 2018-02-05 |
| Est. Completion | 2024-03-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03229941
The ClinicalTrials.gov registry entry for NCT03229941 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,424 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Transfusion is the first listed.
NCT03229941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03229941 about?
NCT03229941 is a clinical study titled "Transfusion Trigger After Operations in High Cardiac Risk Patients". The goal of the proposed study is to determine whether a liberal transfusion strategy (transfusion trigger at Hb \< 10 gm/dl) in Veterans at high cardiac risk who undergo major open vascular and general surgery operations is associated with decreased risk of adverse postoperative outcomes compared t...
What is the current status of trial NCT03229941?
This trial is currently completed. It is a NA study. The enrollment target is 1,424 participants. The study started on 2018-02-05. Estimated completion is 2024-03-02.
What interventions are being tested in trial NCT03229941?
The interventions under investigation include: Blood Transfusion (PROCEDURE).
Who is sponsoring clinical trial NCT03229941?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.